Finance

Lists
Why is BLSM down 3.57%?
Dive Deeper
BLSM:NASDAQ
BlossomHill Therapeutics Inc
$14.59
-3.57%
(-0.54) 1D
$14.59
0.00% (0.00)
After hours
Closed: Nov 18, 4:00:01 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BLSM...
Open
$15.17
High
$16.74
Low
$14.34
Mkt. cap
463.74M
Avg. vol.
173.79K
Volume
0.00
52-wk high
$27.99
52-wk low
$11.02
EPS
-$2.90
No. of employees
71
Open
$15.17
High
$16.74
Low
$14.34
Mkt. cap
463.74M
Avg. vol.
173.79K
Volume
0.00
52-wk high
$27.99
52-wk low
$11.02
EPS
-$2.90
No. of employees
71
News stories
From web sources and news partners
About BlossomHill Therapeutics Inc
CEO-
Employees71
Founded2020
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Analyst ratings
Based on 5 analysts giving stock ratings to BLSM in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for BLSM in the last 3 months.
Highest
Current $14.59
$40.00 (+174.16%)
Average
$36.75 (+151.88%)
Lowest
$32.00 (+119.33%)
Analyst
Recommendation
Action
Price target
Projected
Date
Robert Burns
H.C. Wainwright
Buy
Reiterated
$35.00
+139.9%
11/16/2026
Brian Cheng
J.P. Morgan
Buy
Reiterated
-
-
11/09/2026
Michael Schmidt
Guggenheim
Buy
Reiterated
$40.00
+174.2%
10/22/2026
Andrew Berens
Leerink Partners
Buy
Maintained
$40.00
+174.2%
09/21/2026
Charles Zhu
LifeSci Capital
Buy
Maintained
$32.00
+119.3%
09/15/2026
Last report
Nov 12, 2026
Fiscal period
Q3 2026
-$1.29 / -$0.90
-43.60%miss
Revenue / Est. (USD)
- / 0.00
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
14.67M
19.90M
21.36M
21.93M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.06M
2.21M
3.32M
3.55M
Operating expense
16.73M
22.11M
24.67M
25.48M
Total operating expenses
16.73M
22.11M
24.67M
25.48M
Operating income
-16.73M
-22.11M
-24.67M
-25.48M
Other non operating income
-7.00K
-
-
3.00K
EBT including unusual items
-15.98M
-21.01M
-23.76M
-24.01M
EBT excluding unusual items
-15.98M
-21.01M
-23.76M
-24.01M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-15.98M
-21.01M
-23.76M
-24.01M
Net profit margin
-
-
-
-
Earnings per share
-
-
-8.75
-1.29
Interest and investment income
759.00K
1.10M
915.00K
1.46M
Interest expense
-
-
-
-
Net interest expenses
759.00K
1.10M
915.00K
1.46M
Depreciation and amortization charges
-
-
-
-
EBITDA
-16.63M
-21.98M
-24.54M
-25.35M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google apps